Nancy D Safer from 555 Main St, Providence, RI 02903, age 77, Phone: 401 751-0219

Nancy Safer Phones & Addresses

555 Main St, Providence, RI 02903 • 401 751-0219
555 S Water St APT 316, Providence, RI 02903
Columbia, MO
1610 Tilton Dr, Wheaton, MD 20902 • 301 593-5726
Silver Spring, MD
Reston, VA
555 S Main St APT 316, Providence, RI 02903 • 301 593-5726

Work

Position:

Consultant

Education

Degree:

Associate degree or higher

Skills

Cae

Industries

Education Management

Name / Title

Company / Classification

Phones & Addresses

Nancy Safer
Principle

Gasification Technologies Council
Oil & Energy · Crude Petroleum/Natural Gas Production · Professional Organizations

3030 Clarendon Blvd SUITE 330, Arlington, VA 22201
4301 Fairfax Dr, Arlington, VA 22203
4601 Fairfax Dr, Arlington, VA 22203
703 276-0110, 703 276-7662

Us Patents

Aav4 Vector And Uses Thereof
view source
US Patent:

20100227407, Sep 9, 2010
Filed:

Mar 8, 2010
Appl. No.:

12/719671
Inventors:

John A. Chiorini - Kensington MD, US
Robert M. Kotin - Bethesda MD, US
Brian Safer - Silver Spring MD, US
Nancy Safer - Silver Spring MD, US
Assignee:

US Department of Health and Human Services, National Institutes of Health - Bethesda MD
International Classification:

C12N 7/00
C12N 15/63
US Classification:

435457, 4353201
Abstract:

The present invention provides an adeno-associated virus 4 (AAV4) virus and vectors and particles derived therefrom. In addition, the present invention provides methods of delivering a nucleic acid to a cell using the AAV4 vectors and particles.

Aav4 Vector And Uses Thereof
view source
US Patent:

20130337543, Dec 19, 2013
Filed:

Jul 2, 2013
Appl. No.:

13/933382
Inventors:

Nancy Safer - , US
Brian Safer - Silver Spring MD, US
Nancy Safer - Silver Spring MD, US
Assignee:

The USA, as represented by the Secretary, Department of Health and Human Services - Bethesda MD
International Classification:

C12N 15/63
US Classification:

4352351, 4353201, 530350
Abstract:

The present invention provides an adeno-associated virus 4 (AAV4) virus and vectors and particles derived therefrom. In addition, the present invention provides methods of delivering a nucleic acid to a cell using the AAV4 vectors and particles.